# altcoin / # bitcoin / # blockchain / # exchange / # events / # ICO / # trends / # finance / # Russian news

Bristol Myers Squibb’s stock soars after rival AbbVie reports disappointing schizophrenia-drug trial

2024-11-11 06:44 pm NEWS
Bristol Myers Squibb Co. shares surged 12.5% Monday after rival AbbVie Inc. reported disappointing results from the trial of a new schizophrenia drug.
Read The Rest at
marketwatch.com
bristol myers squibb stock soars after rival abbvie reports disappointing schizophrenia trial
SOURCE:

You May Also Like

1 "We're Coming After You" - How Some On The Left Found Peace Through Hate
"We're Coming After You" - How Some On The Left Found Peace Through Hate
2 Justin Sun stakes $154M in Ethereum —Now holds more ETH than TRX
Justin Sun stakes $154M in Ethereum —Now holds more ETH than TRX
3 Binance Founder CZ Finishes Editing Memoir, Mentions Jail Details
Binance Founder CZ Finishes Editing Memoir, Mentions Jail Details
4 Bitcoin & Ethereum Social Sentiment Collapses, But XRP Just Sees Disinterest
Bitcoin & Ethereum Social Sentiment Collapses, But XRP Just Sees Disinterest
5 Bitcoin fell from 2025’s ‘hottest trade,’ but attention will return: Alex Thorn
Bitcoin fell from 2025’s ‘hottest trade,’ but attention will return: Alex Thorn



© 2022 CRYPTONEWS
Cryptocurrency news – Bitcoin, etherium, altcoins, Blockchain, crypto exchange, law regulation | donate